Wu-Juan Sun | Soil remediation | Best Researcher Award | 13547

Assoc Prof Dr. Wu-Juan Sun | Soil remediation | Best Researcher Award 

Assoc Prof Dr. Wu-Juan Sun, Xi’an Shiou University, China

Dr. Wu-Juan Sun is an Associate Professor and Deputy Director of the Department of Applied Chemistry at Xi’an Shiyou University, China. Holding a Ph.D. in Chemistry from Northwest University, she has led impactful research since 2015 in Microbial Enhanced Oil Recovery (MEOR) and the bioremediation of petroleum-contaminated environments. Her work focuses on developing microbial activators for low-permeability reservoirs, field-scale remediation technologies, and green chemistry approaches such as photoinduced catalytic reactions. Dr. Sun has authored several high-impact publications and plays a key role in managing academic and research initiatives within her department.

Scopus

Education

Dr. Wu-Juan Sun (孙妩娟) began her academic journey with a strong foundation in the field of chemistry. She pursued her Ph.D. in Chemistry at Northwest University, Xi’an, China—one of the country’s leading institutions known for scientific research and innovation. Her doctoral research laid the groundwork for her future specialization in applied environmental chemistry and biotechnology, particularly within the realms of petroleum-based pollution control and microbial processes.

Her Ph.D. experience was characterized by a solid blend of theoretical learning and laboratory practice, giving her a deep understanding of organic chemistry, microbial systems, and environmental bioremediation techniques. This rigorous academic environment nurtured her scientific curiosity and prepared her for a career that would eventually bridge industrial challenges and microbial solutions.

Experience

Since 2015, Dr. Sun has been serving as an Associate Professor and Deputy Director of the Department of Applied Chemistry at Xi’an Shiyou University, a key institution in China’s petroleum and chemical engineering education landscape. In this dual role, she manages academic programming and research initiatives while also leading laboratory operations.

Her leadership at Xi’an Shiyou University has emphasized both innovation and mentorship. She has overseen numerous student research projects and collaborations with industrial partners, especially in the field of Microbial Enhanced Oil Recovery (MEOR) and environmental bioremediation. Her administrative role complements her research leadership, making her a central figure in shaping the university’s applied chemistry strategies.

Research Focus

Her pioneering work involves the development of microbial activators tailored for low-permeability oil reservoirs, aimed at maximizing crude oil extraction using environmentally sustainable processes. Her recent studies explore biodegradation using Chelatococcus daeguensis HB-4, revealing significant advancements in MEOR techniques. She has contributed significantly to the field-scale application of microbial consortia to remediate petroleum-contaminated soils and industrial oily sludge. Her 2024 publication in Environmental Geochemistry and Health detailed pilot-scale studies that have practical implications for real-world oil spill remediation. In line with sustainable development, Dr. Sun explores photoinduced catalytic reactions in organic synthesis. Her recent article in Organic Letters presents innovative [3+2] cycloaddition reactions, showing her ability to merge fundamental chemistry with applied environmental science.

Award and Recognition

Dr. Wu-Juan Sun has earned recognition within the scientific community through her peer-reviewed publications in internationally respected journals such as Bioresource Technology, Ecotoxicology and Environmental Safety, and World Journal of Microbiology & Biotechnology. Her collaborative work, often co-authored with leading scholars like Dr. C.-Y. Ke and Dr. X.-L. Zhang, underlines her academic credibility and teamwork skills.

Her research on bioremediation and MEOR has attracted institutional support, and her leadership as Deputy Director has positioned her as an influential voice in applied chemistry education and research in China.

Publications 

📘 Pilot-scale field studies on activated microbial remediation of petroleum-contaminated soil – Environmental Geochemistry and Health(2024) – cited by 5 articles.
📘 Microbial enhanced oil recovery (MEOR): recent development and future perspectives – Biotechnol(2024) – Cited by 13 articles.
📘Biotreatment of oil sludge containing hydrocarbons by Proteus mirabilis SB – Environmental Technology & Innovation(2021) – Cited by 21 articles.

 

 

 

Soumitra Moulick | Microbiology | Best Researcher Award | 13395

Mr. Soumitra Moulick | Microbiology | Best Researcher Award

Mr. Soumitra Moulick, TCG Lifesciences Pvt. Ltd., India

Mr. Soumitra Moulick, Lead Scientist at TCG Lifesciences Pvt. Ltd., brings over 18 years of expertise in drug discovery research, with impactful contributions in antimicrobial, anti-inflammatory, and anticancer therapeutics. Currently pursuing a PhD at NIT Raipur, he has published peer-reviewed papers and is engaged in an ICMR-funded project on antibiotic-resistant E. coli. His work has supported over 15 global collaborations with pharmaceutical leaders, earning recognition including a best poster award at IIIT Allahabad. His consistent commitment to innovation and translational science underscores his suitability for the Best Researcher Award.

Profile

Scopus

🎓 Early Academic Pursuits

Mr. Soumitra Moulick embarked on his academic journey with a Master’s degree from a reputed Indian university, laying a strong foundation in life sciences and pharmacological research. From the beginning, his keen interest in drug discovery and therapeutic development drove him to pursue in-depth studies in microbiology, pharmacology, and biochemistry. His academic dedication was further demonstrated when he enrolled in a PhD program at the prestigious National Institute of Technology (NIT), Raipur, where he continues to explore advanced research in antibacterial drug discovery. His early education equipped him with a robust scientific mindset and set the stage for a dynamic career in the pharmaceutical sector.

🧪 Professional Endeavors

Mr. Moulick has devoted over 18 years of his professional life to TCG Lifesciences Pvt. Ltd., Kolkata, one of India’s leading Contract Research Organizations (CROs). Rising through the ranks, he currently serves as a Lead Scientist in the In-vitro Pharmacology Department. In this role, he has led and collaborated on more than 15 drug discovery projects, targeting diseases in the therapeutic areas of oncology, infectious diseases, and inflammation.

His work spans protocol development, in-vitro screening, target validation, and assay optimization. Mr. Moulick has worked closely with world-renowned pharmaceutical companies such as Pfizer, Roche, Takeda, Grunenthal, MMV, and DNDi, showcasing his ability to integrate scientific rigor with industry demands. His career at TCG Lifesciences stands as a testament to his commitment, technical excellence, and leadership in translational research.

🔬 Contributions and Research Focus

Mr. Moulick’s primary research interests lie in antimicrobial resistance (AMR), anti-inflammatory therapeutics, and oncology drug discovery. His doctoral research focuses on antibiotic-resistant Escherichia coli, a major causative agent of urinary tract infections. This work is supported by the Indian Council of Medical Research (ICMR) under Grant No. DDR/IIRP23/0569.

He has already published two peer-reviewed research articles in reputed journals such as Microbial Drug Resistance and Microbial Pathogenesis. Despite the limitations on publishing often faced in CRO environments, Mr. Moulick has successfully balanced industry confidentiality with academic contribution. His scientific research emphasizes innovation, with a focus on identifying novel molecular targets, validating high-throughput screening methodologies, and exploring natural and synthetic compound libraries for drug efficacy.

🏅 Accolades and Recognition

Mr. Moulick’s contributions have not gone unnoticed. His poster presentation at the International Webinar cum Workshop on Recent Developments in Applied Biotechnology (organized by IIIT Allahabad) was honored with a Best Poster Award, reflecting the academic community’s recognition of his impactful research.

One of his recent publications received a provisional selection for the “Best Researcher Award”, further validating the significance and originality of his scientific output. In addition to this, he is currently in the process of contributing a book chapter, and he has one patent under review, indicating his continued engagement in knowledge creation and technology transfer.

🌍 Impact and Influence

Over nearly two decades, Mr. Moulick has significantly influenced both industry and academic research through his extensive project experience and collaborative spirit. His ability to work with global pharmaceutical giants has not only enhanced the credibility of Indian CROs but also brought innovative therapeutic candidates closer to clinical application.

His research on antibiotic resistance has real-world implications, particularly in the context of rising multidrug-resistant infections. By identifying alternative treatment strategies and molecular targets, Mr. Moulick’s work contributes meaningfully to public health and global medicine. His influence extends across laboratories, boardrooms, and academic institutions, as he frequently engages in collaborative projects that bridge academia and industry.

🌟 Legacy and Future Contributions

Looking ahead, Mr. Moulick is poised to further strengthen his contributions to drug discovery and biomedical innovation. His future endeavors include completing his PhD with a high-impact third publication, finalizing his patent application, and authoring a comprehensive book chapter that can serve as a resource for young researchers and professionals.

He aims to mentor early-career scientists in preclinical research and build a legacy of scientific excellence, collaboration, and integrity. With a vision to drive innovative, affordable, and accessible therapeutics, Mr. Moulick is committed to being a catalyst for change in the Indian and global pharmaceutical landscape.

His unique blend of academic rigor, industrial experience, and collaborative mindset makes him a valuable contributor to the scientific community, and his nomination for the Best Researcher Award is both timely and well-deserved.

Publication Top Notes

Author: S., Moulick, Soumitra, D.N., Roy, Dijendra Nath

Journal: Microbial Pathogenesis

Year: 2025

Bioflavonoid Baicalein Modulates Tetracycline Resistance by Inhibiting Efflux Pump in Staphylococcus aureus

Author: Soumitra Moulick and Dijendra Nath Roy

Journal: Microbial Drug Resistance

Year: 2024